Your browser doesn't support javascript.
loading
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.
Pataskar, Abhijeet; Champagne, Julien; Nagel, Remco; Kenski, Juliana; Laos, Maarja; Michaux, Justine; Pak, Hui Song; Bleijerveld, Onno B; Mordente, Kelly; Navarro, Jasmine Montenegro; Blommaert, Naomi; Nielsen, Morten M; Lovecchio, Domenica; Stone, Everett; Georgiou, George; de Gooijer, Mark C; van Tellingen, Olaf; Altelaar, Maarten; Joosten, Robbie P; Perrakis, Anastassis; Olweus, Johanna; Bassani-Sternberg, Michal; Peeper, Daniel S; Agami, Reuven.
Afiliación
  • Pataskar A; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Champagne J; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nagel R; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kenski J; Division of Molecular Oncology and Immunology, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Michaux J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Pak HS; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Bleijerveld OB; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Mordente K; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Navarro JM; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Blommaert N; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nielsen MM; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lovecchio D; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Stone E; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Georgiou G; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • de Gooijer MC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • van Tellingen O; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Altelaar M; Department of Molecular Biosciences, University of Texas, Austin, TX, USA.
  • Joosten RP; Department of Molecular Biosciences, University of Texas, Austin, TX, USA.
  • Perrakis A; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Olweus J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bassani-Sternberg M; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Peeper DS; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.
  • Agami R; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nature ; 603(7902): 721-727, 2022 03.
Article en En | MEDLINE | ID: mdl-35264796
ABSTRACT
Activated T cells secrete interferon-γ, which triggers intracellular tryptophan shortage by upregulating the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme1-4. Here we show that despite tryptophan depletion, in-frame protein synthesis continues across tryptophan codons. We identified tryptophan-to-phenylalanine codon reassignment (W>F) as the major event facilitating this process, and pinpointed tryptophanyl-tRNA synthetase (WARS1) as its source. We call these W>F peptides 'substitutants' to distinguish them from genetically encoded mutants. Using large-scale proteomics analyses, we demonstrate W>F substitutants to be highly abundant in multiple cancer types. W>F substitutants were enriched in tumours relative to matching adjacent normal tissues, and were associated with increased IDO1 expression, oncogenic signalling and the tumour-immune microenvironment. Functionally, W>F substitutants can impair protein activity, but also expand the landscape of antigens presented at the cell surface to activate T cell responses. Thus, substitutants are generated by an alternative decoding mechanism with potential effects on gene function and tumour immunoreactivity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triptófano / Triptófano-ARNt Ligasa Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triptófano / Triptófano-ARNt Ligasa Idioma: En Revista: Nature Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos